Last reviewed · How we verify
Cluster Headache Prevention
Approved treatments
- Norgesic · Hikma
- Ergot · Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- phenobarbitone · Institute of Child Health
- PF-07976016 Formulation A · Pfizer
- Migergot
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Cluster Headache Prevention patent landscape — cliff calendar, originator estates, attackable patents
- Cluster Headache Prevention treatment landscape brief
- Cluster Headache Prevention treatment updates RSS
Frequently asked questions about Cluster Headache Prevention
What drugs treat Cluster Headache Prevention?
Tracked treatments include Norgesic, Ergot, phenobarbitone, PF-07976016 Formulation A, Migergot.
What is the treatment for Cluster Headache Prevention?
Standard treatment for Cluster Headache Prevention includes Norgesic, Ergot, phenobarbitone, PF-07976016 Formulation A, Migergot. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Cluster Headache Prevention patent cliff · Cluster Headache Prevention CI report
- Treatment: Norgesic · Hikma
- Treatment: Ergot · Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- Treatment: phenobarbitone · Institute of Child Health
- Treatment: PF-07976016 Formulation A · Pfizer
- Treatment: Migergot
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing